MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIN, H.-L.
Right arrow Articles by GLAZER, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIN, H.-L.
Right arrow Articles by GLAZER, R. I.

Molecular Pharmacology, Vol 20, 644-648, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

The Comparative Effects of 5-Azacytidine and Dihydro-5-azacytidine on Polysomal RNA in Ehrlich Ascites Cells in Vitro

HSIN-LI LIN 1 and ROBERT I. GLAZER 1

1 Applied Pharmacology Section, Laboratory of Medicinal Chemistry and Biology, National Cancer Institute, Bethesda, Maryland 20205

The comparative effects of 5-azacytidine (AZC) and dihydro-5-azacytidine (DHAZC) on the synthesis of polysomal RNA, as well as the translational activity of drug-modified poly(A)RNA were studied in Ehrlich ascites cells in vitro. AZC inhibited the incorporation of [3H]adenosine into non-poly(A)RNA in a concentration-dependent manner, but did not affect the synthesis of poly(A)RNA. In contrast, neither RNA fraction was significantly affected by equimolar concentrations of DHAZC except at 10-3 M, where 40% inhibition of the synthesis of only non-poly(A)RNA was achieved. Electrophoretic characterization of non-poly(A)RNA revealed that the synthesis of 28 S rRNA was inhibited to a greater extent than was 18 S rRNA by 10-5 M AZC, but to equal extents at 10-4 M drug. Significant inhibition of 28 S and 18 S rRNA occurred only with 10-3 M DHAZC, where approximately 50% inhibition of both rRNA species occurred. Both cytidine analogues were ineffective in inhibiting tRNA synthesis. AZC and DHAZC were incorporated into all species of polysomal RNA, but the amount of drug substitution into a particular species of RNA was not proportional to its effect on the synthesis or function of that RNA. There was more analogue incorporated into poly(A)RNA than into nonpoly(A)RNA, but drug-substituted poly(A)RNA showed neither an impairment of its coding efficiency nor qualitative changes in the translation products synthesized in a rabbit reticulocyte translation system in vitro. From these results, it appears that the relative differences in the inhibitory effects by the two cytidine analogues on rRNA synthesis, as well as their incorporation into rRNA, correlate closely with their relative potencies as antitumor agents.

Submitted on January 27, 1981
Accepted on June 12, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics